---
title: "Inogen, Inc. (INGN.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/INGN.US.md"
symbol: "INGN.US"
name: "Inogen, Inc."
industry: "医疗器械"
---

# Inogen, Inc. (INGN.US)

| Item | Detail |
|------|--------|
| Industry | 医疗器械 |
| Location | 美股市场 |
| Website | [www.inogen.com](https://www.inogen.com) |

## Company Profile

Inogen, Inc.是一家医疗科技公司，在美国和国际市场上开发、制造和销售呼吸健康产品。该公司提供便携式氧气浓缩器，用于为患有慢性呼吸疾病的患者提供补充的长期氧气治疗。公司提供 Inogen One 和 Inogen Rove，作为长期氧气治疗的便携解决方案；Rove 4，便携式氧气浓缩器；Inogen At Home 固定式氧气浓缩器；Simeox 气道清理设备；电池及相关配件。它还直接将产品租赁给患者

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:12.000Z

**Overall: C (0.45)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 78 / 185 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 4.68% |  |
| Net Profit YoY | 51.83% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.80 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 158.28M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 347.03M |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -13.27% | D |
| Profit Margin | -7.31% | D |
| Gross Margin | 44.72% | B |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 4.68% | C |
| Net Profit YoY | 51.83% | B |
| Total Assets YoY | 0.27% | C |
| Net Assets YoY | 6.35% | B |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -1367.49% | E |
| OCF YoY | 4.68% | C |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 1.13 | A |

#### Debt Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 35.78% | B |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Inogen, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-13.27%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-7.31%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "44.72%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "4.68%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "51.83%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "0.27%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "6.35%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-1367.49%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "4.68%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "1.13",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "B",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "35.78%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 启迪医疗 (US.INSP) | A | B | A | A | B | A |
| 02 | Delcath (US.DCTH) | C | A | A | A | A | A |
| 03 | 直觉外科 (US.ISRG) | A | B | C | A | B | B |
| 04 | 史赛克 (US.SYK) | A | B | C | C | B | B |
| 05 | 波士顿科学 (US.BSX) | B | B | C | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -6.24 | 124/181 | - | - | - |
| PB | 0.80 | 22/181 | 1.13 | 0.98 | 0.88 |
| PS (TTM) | 0.46 | 14/181 | 0.63 | 0.55 | 0.51 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-21T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 50% |
| Overweight | 1 | 50% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 5.79 |
| Highest Target | 14.00 |
| Lowest Target | 12.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/INGN.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/INGN.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/INGN.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.